Stocks
Amylyx Pharmaceuticals (AMLX) FCF conversion US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| FCF conversion, % | 90.9% | 90.8% | 26.8% | 57.7% | 85.7% | 80.2% | |||
| Changes by years, y/y, % | -4pp | 0pp | -64pp | +31pp | +28pp | -1.9% | |||
Amylyx Pharmaceuticals. FCF conversion, %
Amylyx Pharmaceuticals. FCF conversion, changes, pp
Amylyx Pharmaceuticals (AMLX) FCF conversion US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| FCF conversion, % | 61.2% | 88.7% | 90.4% | 89.5% | 72.5% | 80.2% | ||
| Changes by years, y/y, % | -64pp | +34pp | -55pp | -16pp | +11pp | |||
| Changes by quarters, q/q, % | -45pp | +28pp | +2pp | -1pp | -17pp | |||
